|34.30||+0.1175||+0.34%||Vol 1.03M||1Y Perf -22.89%|
|Dec 7th, 2023 16:00 DELAYED|
|- -%||- -|
|Target Price||49.78||Analyst Rating||Hold 2.55|
|Potential %||45.13||Finscreener Ranking||★ 39.40|
|Insiders Trans % 3/6/12 mo.||-100/-100/-100||Value Ranking||★ 41.05|
|Insiders Value % 3/6/12 mo.||-100/-100/-100||Growth Ranking||★★★+ 54.33|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/-100/-100||Income Ranking||★+ 36.05|
|Price Range Ratio 52W %||25.51||Earnings Rating||Sell|
|Market Cap||6.22B||Earnings Date||8th Nov 2023|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||-|
|Estimated EPS Next Report||0.65|
|EPS Growth Next 5 Years %||8.20|
|Avg. Weekly Volume||1.03M|
|Avg. Monthly Volume||1.55M|
|Avg. Quarterly Volume||1.21M|
Genpact Limited (NYSE: G) stock closed at 34.3 per share at the end of the most recent trading day (a 0.34% change compared to the prior day closing price) with a volume of 1.03M shares and market capitalization of 6.22B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Software industry, Technology sector and employs 96300 people. Genpact Limited CEO is N. V. Tyagarajan.
The one-year performance of Genpact Limited stock is -22.89%, while year-to-date (YTD) performance is -25.95%. G stock has a five-year performance of 20.69%. Its 52-week range is between 29.4101 and 48.58, which gives G stock a 52-week price range ratio of 25.51%
Genpact Limited currently has a PE ratio of 26.40, a price-to-book (PB) ratio of 4.95, a price-to-sale (PS) ratio of 2.61, a price to cashflow ratio of 19.20, a PEG ratio of 3.22, a ROA of 7.64%, a ROC of 10.05% and a ROE of 19.89%. The company’s profit margin is 8.07%, its EBITDA margin is 14.80%, and its revenue ttm is $3.27 Billion , which makes it $17.84 revenue per share.
Of the last four earnings reports from Genpact Limited, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.65 for the next earnings report. Genpact Limited’s next earnings report date is -.
The consensus rating of Wall Street analysts for Genpact Limited is Hold (2.55), with a target price of $49.78, which is +45.13% compared to the current price. The earnings rating for Genpact Limited stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Genpact Limited has a dividend yield of 1.07% with a dividend per share of $0.50 and a payout ratio of 25.00%.
Genpact Limited has a Neutral technical analysis rating based on Technical Indicators (ADX : 6.08, ATR14 : 0.78, CCI20 : 57.51, Chaikin Money Flow : 0.09, MACD : 0.00, Money Flow Index : 44.44, ROC : 0.35, RSI : 51.94, STOCH (14,3) : 61.54, STOCH RSI : 0.45, UO : 61.51, Williams %R : -38.46), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Genpact Limited in the last 12-months were: Balkrishan Kalra (Option Excercise at a value of $1 301 868), Balkrishan Kalra (Sold 67 280 shares of value $3 135 625 ), Carol Lindstrom (Sold 4 308 shares of value $205 319 ), Darren Saumur (Option Excercise at a value of $2 447 247), Darren Saumur (Sold 85 036 shares of value $3 837 262 ), Heather D. White (Sold 5 225 shares of value $244 127 ), Kalra Balkrishan (Option Excercise at a value of $1 301 868), Kalra Balkrishan (Sold 67 280 shares of value $3 135 667 ), Kathryn A. Stein (Option Excercise at a value of $1 246 500), Kathryn A. Stein (Sold 55 500 shares of value $2 624 738 ), Mehta Piyush (Option Excercise at a value of $628 875), Mehta Piyush (Sold 206 025 shares of value $7 860 457 ), Morken Cecelia (Buy at a value of $184 650), N. V. Tyagarajan (Option Excercise at a value of $32 895 000), N. V. Tyagarajan (Sold 1 700 000 shares of value $76 759 362 ), Stein Kathryn (Sold 0 shares of value $-1 246 500 ), Stein Kathryn (Sold 55 500 shares of value $2 624 700 ), White Heather (Option Excercise at a value of $393 750), White Heather (Sold 17 725 shares of value $753 112 )
Wed, 16 Aug 2023 20:34 GMT McKesson extends relationship with Genpact to streamline its finance processes- TipRanks. All rights reserved.
Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
General partner of Finscreener is SLOVAKODATA, a.s.
This could take some time, please wait.